Top Markets
#1 DogBull DogBull +105.49%
#2 Siacoin Siacoin +51.54%
#3 UnifAI Network UnifAI Network +48.39%
#4 ADO Protocol ADO Protocol +46.41%
#5 MarsCoin MarsCoin +37.41%
#6 Magma Finance Magma Finance +30.45%
#7 Useless Coin Useless Coin +26.46%
#8 Ontology Gas Ontology Gas +19.20%
#9 Nockchain Nockchain +16.75%
#10 Cash Cat Cash Cat +14.98%
Coin of the day
DogBull DogBull
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Opus Genetics, Inc. Opus Genetics, Inc.

Opus Genetics, Inc.

IRD
Classifica tra le azioni #16217
Opus Genetics, Inc. is a clinical-stage biopharmaceutical company focused on... Opus Genetics, Inc. is a clinical-stage biopharmaceutical company focused on ophthalmology. The company is dedicated to discovering and commercializing innovative therapies to address significant unmet medical needs in patients suffering from refractive and retinal eye disorders. Its portfolio includes Phentolamine Ophthalmic Solution, currently used to reverse pharmacologically induced mydriasis (pupil dilation). This solution is also advancing through Phase III clinical trials for the treatment of presbyopia and impaired vision in dim light or at night. A leading candidate in its retinal pipeline is APX3330, a small-molecule inhibitor targeting the reduction oxidation effector factor-1 protein. APX3330 has successfully completed Phase II clinical trials for diabetic retinopathy. Furthermore, Opus Genetics is developing APX2009 and APX2014, two preclinical product candidates also aimed at various retinal indications. Originally founded in 2018 as Ocuphire Pharma, Inc., the company maintains its headquarters in Farmington Hills, Michigan.
Prezzo delle azioni
$3.70
Ultima sincronizzazione: 2026-07-31
Capitalizzazione di mercato
$305.87M
Variazione (1 giorno)
-3.53%
Variazione (1 anno)
203.66%
Paese
US
Scambia Opus Genetics, Inc. (IRD)

Categoria

Healthcare
Storico dividendi per Opus Genetics, Inc. (IRD)
Opus Genetics, Inc. (simbolo azionario: IRD) ha effettuato un totale di 0 pagamenti di dividendi.
La somma totale dei dividendi (rettificata per split azionari) è: 0.00
Rendimento da dividendo (TTM): 0
Pagamenti dei dividendi per Opus Genetics, Inc. (IRD) dal 2026 al 2026
Pagamenti annuali dei dividendi
Anno Dividendo (rettificato per split azionari) Cambia
Non abbastanza dati per le date fornite.
Elenco di tutti i pagamenti di dividendi
Anno Dividendo Cambia
Non abbastanza dati per le date fornite.
Dividendi di aziende simili o concorrenti
Azienda Numero di pagamenti di dividendi Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH